Prednisolone and Eye movement disorder - a phase IV clinical study of FDA data

Summary:

Eye movement disorder is reported as a side effect among people who take Prednisolone (prednisolone), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Methylprednisolone, and have Spinal muscular atrophy.

The phase IV clinical study analyzes which people have Eye movement disorder when taking Prednisolone. It is created by eHealthMe based on reports of 211,370 people who have side effects when taking Prednisolone from the FDA, and is updated regularly.

What is Prednisolone?

Prednisolone has active ingredients of prednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 212,675 Prednisolone users. Check the latest studies of Prednisolone.

What is Eye movement disorder?

Eye movement disorder is found to be associated with 609 drugs and 902 conditions by eHealthMe. Check the latest studies of Eye movement disorder.

On Jul, 06, 2026

211,370 people reported to have side effects when taking Prednisolone.
Among them, 103 people (0.05%) have Eye movement disorder.

Could Prednisolone cause Eye movement disorder?

Among these 103 people:

How long have people been on Prednisolone when they have Eye movement disorder? *

Click here to view more results

What is the gender of people who have Eye movement disorder when taking Prednisolone? *

Click here to view

What is the age of people who have Eye movement disorder when taking Prednisolone? *

Click here to view more results

* Approximation only. Some reports may have incomplete information.

Do you take Prednisolone and have Eye movement disorder?

- Check whether Eye movement disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Prednisolone:

Prednisolone (212,675 reports)

Eye movement disorder treatments and more:

Eye movement disorder (7,501 reports)

How severe was Eye movement disorder and when was it recovered:

Eye movement disorder in Prednisolone

Expand to all the drugs that have ingredients of prednisolone:

Eye movement disorder and drugs with ingredients of prednisolone

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Prednisolone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eye movement disorder:

Eye movement disorder (609 drugs)

Browse all the conditions that are associated with Eye movement disorder:

Eye movement disorder (902 conditions)

Related publications that referenced our studies

Abdullah, D., Mohamed, A. M. F. S., & Liew, A. K. C., "Dentine hypersensitivity-like tooth pain associated with the use of high-dose steroid therapy", Journal of conservative dentistry: JCD, 2018 Jan .
Abdullah, D., Mohamed, A. M. F. S., & Liew, A. K. C., "Dentine hypersensitivity-like tooth pain associated with the use of high-dose steroid therapy", Journal of conservative dentistry: JCD, 2018 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on prednisolone (the active ingredients of Prednisolone) and Prednisolone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.